ArticleCancers2026

TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High-Dose-Rate Brachytherapy.

Magdalena Jarosz-Biej et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.